The Significance of Prostate Specific Antigen Persistence in Prostate Cancer Risk Groups on Long-Term Oncological Outcomes

SIMPLE SUMMARY: The current prostate cancer guidelines recommend performing the first prostate-specific antigen measurement at three months after radical prostatectomy. However, at an earlier measurement, persistence (≥0.1 ng/mL) of this biomarker could be found in up to 30% of cases, depending on t...

Descripción completa

Detalles Bibliográficos
Autores principales: Milonas, Daimantas, Venclovas, Zilvinas, Sasnauskas, Gustas, Ruzgas, Tomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8158093/
https://www.ncbi.nlm.nih.gov/pubmed/34070052
http://dx.doi.org/10.3390/cancers13102453

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8158093/
https://www.ncbi.nlm.nih.gov/pubmed/34070052
http://dx.doi.org/10.3390/cancers13102453

Ejemplares similares